1. Ahn, S. H., Monsanto, S. P., Miller, C., Singh, S. S., Thomas, R., & Tayade, C. (2015). Pathophysiology and immune dysfunction in endometriosis. BioMed Research International, 2015, 795976.
2. American College of Obstetricians and Gynecologists. (2010). Management of endometriosis (Practice Bulletin No. 114). Obstetrics & Gynecology, 116, 223–236.
3. Biscotti, C., & Ray, N. (2010). Papanicolaou tests associated with cervical mucosal endometriosis: An analysis of cellular features and c omparison to endocervical adenocarcinoma in situ. Diagnostic Cytopahology, 38, 551–554.
4. Cobb, J. (2008). Endometriosis. In D. C. Wilbur & M. R. Henry (Eds.), College of American pathologists practical guide to gynecologic cytopathology. Illinois: College of American Pathologists.
5. Gadducci, A., Lanfredini, N., & Tana, R. (2014). Novel insights on the malignant transformation of endometriosis into ovarian carcinoma. Gynecological Endocrinology, 30, 612–617.